Immediate Mobilization After Plate Osteosynthesis of Proximal Tibial Fractures - A Cohort Study (IMOP)

March 15, 2021 updated by: Eske Brand, Slagelse Hospital

The purpose of this study is to investigate if immediate mobilization with weight bearing as tolerated following surgery with plates and screws after a fracture of the shinbone near the knee is possible without increased risk.

The investigators hypothesize immediate weight bearing as tolerated following surgery with plates and screws of the above mentioned fracture, in cases deemed stable by the surgeon, will not lead to any loss of reduction.

Study Overview

Detailed Description

The purpose of this study is to investigate immediate mobilization with weight bearing as tolerated following plate osteosynthesis after a proximal tibial plateau fracture is possible without increased risk of loss of reduction and/or failure of the osteosynthesis. Subsequently, this may lead to earlier recovery and less risk of thromboembolic complications.

The investigators hypothesize immediate weight bearing as tolerated (WBAT) following plate osteosynthesis after a proximal tibial plateau fracture, in cases deemed stable by the surgeon, will not lead to any loss of reduction.

Exposure will be defined as surgery with one or two angular stable plates (closed reduction, internal fixation) after a proximal tibial fracture. Patients will be allowed immediate weight bearing as tolerated in cases where the osteosynthesis is deemed stable. This represents the current practice at Slagelse Hospital. Typical, all lateral tibia plateau fractures (AO fracture classification 41B1-3) osteosynthesized will be allowed immediate WBAT after surgery. Other tibia plateau fractures will be allowed immediate WBAT if the osteosynthesis is deemed stable by the surgeon perioperatively.

Fractures are treated with one or several locking plates, and if needed after reduction of the tibial plateau, an impacted allogenic bone graft is used. The bone graft is applied through a cortical window osteotomy distal to the fracture.

Follow up will be performed at 2 weeks, 6 weeks, 3 months, 6 months and 1 year by any of the authors or a consultant in orthopedics. Follow up will be performed at the outpatient clinic.

Study Type

Observational

Enrollment (Actual)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Slagelse, Denmark, 4200
        • Slagelse Sygehus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Every patient hospitalized at Slagelse hospital with proximal tibial fracture needing surgery with plates and screws residing in Slagelse hospital uptake area

Description

Inclusion Criteria:

  • Patient hospitalized and osteosynthesized with one or several locking plates because of a proximal tibial fracture

Exclusion Criteria:

  • Non-ambulatory patients,
  • Patients diagnosed with dementia and
  • Patients residing to another hospital

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Loss of reduction
Time Frame: Day 0 to one year after surgery.
Loss of reduction/fracture collapse after ambulation measured by x ray
Day 0 to one year after surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: Day 0 to one year after surgery.
KOOS is a self-reported questionnaire comprising five subscales: pain, other symptoms, activities in daily living (ADL), function in sport and recreation and knee-related quality of life (QOL). The previous week is taken into consideration when patients are answering the questions. Standardized answer options are given (5 boxes on a Likert scale) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
Day 0 to one year after surgery.
Return to Work
Time Frame: Day 0 to one year after surgery.
If the subject hasnt worked prior to surgery, normal activity will be measured instead.
Day 0 to one year after surgery.
Length of Hospital Stay
Time Frame: Day 0 to one year after surgery.
Day 0 to one year after surgery.
Euroqol 5 Dimension (EQ-5D)
Time Frame: Day 0 to one year after surgery.
The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems (1), some problems (2), and extreme problems (3). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results into a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
Day 0 to one year after surgery.
The University of California at Los Angeles (UCLA) Activity Score
Time Frame: Day 0 to one year after surgery.
A Danish version of the UCLA activity score will be used to assess the activity level before and after they have undergone surgery. The patients will answer the questionnaire preoperative and at the appointments in the outpatient clinic. The UCLA activity score ranges from 1-10 (not active-highly active) and the patient has to choose one out of the ten options based on their activity level for the past four weeks.
Day 0 to one year after surgery.
Radiographic Osteoarthritis
Time Frame: Day 0 to one year after surgery.
Kellgren and Lawrence score
Day 0 to one year after surgery.
Status of reoperation
Time Frame: Day 0 to one year after surgery.
Day 0 to one year after surgery.
Performance Measures
Time Frame: Day 0 to one year after surgery.
Knee range of motion
Day 0 to one year after surgery.
Status of surgery for acute compartment syndrome
Time Frame: Day 0 to 2 weeks after
Day 0 to 2 weeks after
Wound rupture
Time Frame: Day 0 to 6 weeks after
Wound rupture needing suturing based on the evaluation by the investigators or a senior consultant
Day 0 to 6 weeks after
Infection
Time Frame: Day 0 to one year after surgery.
Infection needing antibiotics, based on clinical findings combined with blodsamples measuring CRP and leucocytes.
Day 0 to one year after surgery.
Symptomatic deep venous thrombosis (DVT)
Time Frame: Day 0 to 6 weeks after
Symptomatic DVT will be verified/disproved by ultrasound of the lower leg.
Day 0 to 6 weeks after

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2018

Primary Completion (Actual)

January 31, 2021

Study Completion (Actual)

February 28, 2021

Study Registration Dates

First Submitted

October 9, 2017

First Submitted That Met QC Criteria

October 15, 2017

First Posted (Actual)

October 19, 2017

Study Record Updates

Last Update Posted (Actual)

March 16, 2021

Last Update Submitted That Met QC Criteria

March 15, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 59459

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery--Complications

Clinical Trials on Weight bearing as tolerated

Subscribe